COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Resolutions of the 13th Meeting of the Fifth Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd.

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2014-022

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on Resolutions of the Thirteenth Meeting of the Fifth Board

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

The 13th meeting of the 5th Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) was held on March 26, 2014 by way of on-site voting. The meeting was notified by telephone, electronic on March 24, 2014. Emission by mail, etc., in accordance with the provisions of the "Company Law" and "Articles of Association". The meeting should attend 7 directors and actually attend 7 directors. The convening of this meeting is in line with the relevant provisions of the Company Law and the Articles of Association. The convening procedures and voting results of this meeting are legal and valid.

The meeting was held in the conference room of the company. After careful consideration by the directors at the meeting, the following proposals were passed:

1. The “Proposal on Nominating the Independent Directors of the Fifth Session of the Board of Directors” was reviewed and approved.

The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.

In view of the resignation of the independent director of the company, Ms. Li Fei, on March 26, 2014, she resigned from the position of the company's audit committee and nomination committee, and responded to the relevant laws, regulations and articles of association of the state, and responded to the independent director of the fifth board of directors of the company. Make a by-election.

The Nomination Committee of the Board of Directors of the Company officially nominated Mr. Zhang Lianxue as the independent director of the fifth board of directors in accordance with the provisions of the Articles of Association.

2. The “Proposal on Nominating the Non-Independent Directors of the Fifth Session of the Board of Directors” was reviewed and approved.

The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.

In view of the chairman of the company, Mr. Cao Enhui, the directors Mr. Zu Chunxiang and Mr. Yin Jinlong resigned as directors on March 26, 2014. At the same time, they resigned from the company's relevant special committees and responded to the company's regulations in accordance with relevant national laws, regulations and articles of association. The directors of the fifth board of directors conduct a by-election

According to the company's articles of association, Dunhua Kangping Investment Co., Ltd., the company's largest shareholder, officially recommended to the company that Mr. Zhang Zhongwei, Ms. Li Baozhi and Ms. Zhong Yunxiang were the non-independent directors of the fifth board of directors.

The independent directors of the company issued independent opinions on the above proposal, and the above proposal still needs to be submitted to the company's second extraordinary shareholders meeting in 2014 for consideration. The board of directors of the company stated that after the replacement of the directors, the total number of directors who are concurrently the senior management of the company among the members of the fifth board of directors of the company shall not exceed one-half of the total number of directors of the company. Announcement on Directors, Independent Directors, Supervisors Resignation and By-election of Directors, Independent Directors and Supervisors, Statement of Candidates for Independent Directors, and Statement of Nominees for Independent Directors See the company's designated information disclosure media www.cninfo.com .cn) and the company's designated information disclosure media.

3. The “Proposal on Convening the Second Extraordinary General Meeting of 2014” was considered and approved.

The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.

The company is scheduled to hold the second extraordinary shareholders meeting of 2014 in the conference room of No. 137 Dongtoudao Street, Nanguan District, Changchun City at 9:00 am on Friday, April 11, 2014.

The full text of the Notice on Convening the Second Extraordinary General Meeting of 2014 was published on www.cninfo.com.cn and the company's designated information disclosure media.

4. The “Proposal on Appointing Senior Management of the Company” was considered and approved.

Review results: 7 votes in favor, 0 votes against, 0 abstentions

According to the nomination of the general manager of the company, the company's board of directors nomination committee reviewed, appointed Mr. Xu Daqing as the company's deputy general manager, its term of office from the date of the meeting to the expiration of the fifth term of the company's board of directors.

Independent directors of the company issued independent opinions.

5. The “Proposal on Appointing the Chief Financial Officer of the Company” was considered and approved.

Review results: 7 votes in favor, 0 votes against, 0 abstentions

In view of the resignation of Mr. Xu Jifeng, the company's chief financial officer, on March 26, 2014, he was nominated by the Nomination Committee of the company's board of directors and appointed Mr. Zhang Zhongwei as the company's chief financial officer. His term of office is from the date of the meeting to the fifth term of the company's board of directors. At the end of the period.

Independent directors of the company issued independent opinions.

The full text of the "Announcement on the Resignation of Senior Management, Chief Financial Officer and Newly Appointed Senior Management and Chief Financial Officer" was published on www.cninfo.com.cn and the company's designated information disclosure media.

For details of the above-mentioned by-elections and new recruits, please refer to the “Directors, Independent Directors, Supervisors Resignation and By-election Directors, Independent Directors and Supervisors published on the website of www.cninfo.com.cn and the company's designated information disclosure media. Announcement, Announcement on Senior Management, Resignation of Chief Financial Officer and Newly Appointed Senior Management and Chief Financial Officer

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

March 27, 2014